|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:ZFAND3-GRHL2 (FusionGDB2 ID:100224) |
Fusion Gene Summary for ZFAND3-GRHL2 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: ZFAND3-GRHL2 | Fusion gene ID: 100224 | Hgene | Tgene | Gene symbol | ZFAND3 | GRHL2 | Gene ID | 60685 | 79977 |
| Gene name | zinc finger AN1-type containing 3 | grainyhead like transcription factor 2 | |
| Synonyms | TEX27 | BOM|DFNA28|ECTDS|PPCD4|TFCP2L3 | |
| Cytomap | 6p21.2 | 8q22.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | AN1-type zinc finger protein 3testis expressed sequence 27testis-expressed protein 27zinc finger, AN1-type domain 3 | grainyhead-like protein 2 homologbrother of mammalian grainyheadgrainyhead-like 2transcription factor CP2-like 3 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | . | Q6ISB3 | |
| Ensembl transtripts involved in fusion gene | ENST00000287218, ENST00000373391, ENST00000463847, | ENST00000251808, ENST00000395927, ENST00000517674, | |
| Fusion gene scores | * DoF score | 39 X 11 X 14=6006 | 8 X 8 X 5=320 |
| # samples | 43 | 8 | |
| ** MAII score | log2(43/6006*10)=-3.80399590996769 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/320*10)=-2 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: ZFAND3 [Title/Abstract] AND GRHL2 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | ZFAND3(37897775)-GRHL2(102676681), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | ZFAND3-GRHL2 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. ZFAND3-GRHL2 seems lost the major protein functional domain in Tgene partner, which is a transcription factor due to the frame-shifted ORF. ZFAND3-GRHL2 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | GRHL2 | GO:0008544 | epidermis development | 23254293 |
| Tgene | GRHL2 | GO:0044030 | regulation of DNA methylation | 23254293 |
| Tgene | GRHL2 | GO:0045617 | negative regulation of keratinocyte differentiation | 23254293 |
| Tgene | GRHL2 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 23814079 |
| Fusion gene breakpoints across ZFAND3 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across GRHL2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | BRCA | TCGA-C8-A134 | ZFAND3 | chr6 | 37897775 | + | GRHL2 | chr8 | 102676681 | + |
Top |
Fusion Gene ORF analysis for ZFAND3-GRHL2 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000287218 | ENST00000251808 | ZFAND3 | chr6 | 37897775 | + | GRHL2 | chr8 | 102676681 | + |
| Frame-shift | ENST00000287218 | ENST00000395927 | ZFAND3 | chr6 | 37897775 | + | GRHL2 | chr8 | 102676681 | + |
| 5CDS-3UTR | ENST00000287218 | ENST00000517674 | ZFAND3 | chr6 | 37897775 | + | GRHL2 | chr8 | 102676681 | + |
| Frame-shift | ENST00000373391 | ENST00000251808 | ZFAND3 | chr6 | 37897775 | + | GRHL2 | chr8 | 102676681 | + |
| Frame-shift | ENST00000373391 | ENST00000395927 | ZFAND3 | chr6 | 37897775 | + | GRHL2 | chr8 | 102676681 | + |
| 5CDS-3UTR | ENST00000373391 | ENST00000517674 | ZFAND3 | chr6 | 37897775 | + | GRHL2 | chr8 | 102676681 | + |
| intron-3CDS | ENST00000463847 | ENST00000251808 | ZFAND3 | chr6 | 37897775 | + | GRHL2 | chr8 | 102676681 | + |
| intron-3CDS | ENST00000463847 | ENST00000395927 | ZFAND3 | chr6 | 37897775 | + | GRHL2 | chr8 | 102676681 | + |
| intron-3UTR | ENST00000463847 | ENST00000517674 | ZFAND3 | chr6 | 37897775 | + | GRHL2 | chr8 | 102676681 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for ZFAND3-GRHL2 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| ZFAND3 | chr6 | 37897775 | + | GRHL2 | chr8 | 102676681 | + | 4.27E-06 | 0.9999957 |
| ZFAND3 | chr6 | 37897775 | + | GRHL2 | chr8 | 102676681 | + | 4.27E-06 | 0.9999957 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for ZFAND3-GRHL2 |
| Go to FGviewer for the breakpoints of :-: - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| . | GRHL2 |
| FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Transcription factor playing an important role in primary neurulation and in epithelial development (PubMed:29309642, PubMed:25152456). Binds directly to the consensus DNA sequence 5'-AACCGGTT-3' acting as an activator and repressor on distinct target genes (By similarity). During embryogenesis, plays unique and cooperative roles with GRHL3 in establishing distinct zones of primary neurulation. Essential for closure 3 (rostral end of the forebrain), functions cooperatively with GRHL3 in closure 2 (forebrain/midbrain boundary) and posterior neuropore closure (By similarity). Regulates epithelial morphogenesis acting as a target gene-associated transcriptional activator of apical junctional complex components. Up-regulates of CLDN3 and CLDN4, as well as of RAB25, which increases the CLDN4 protein and its localization at tight junctions (By similarity). Comprises an essential component of the transcriptional machinery that establishes appropriate expression levels of CLDN4 and CDH1 in different types of epithelia. Exhibits functional redundancy with GRHL3 in epidermal morphogenetic events and epidermal wound repair (By similarity). In lung, forms a regulatory loop with NKX2-1 that coordinates lung epithelial cell morphogenesis and differentiation (By similarity). In keratinocytes, plays a role in telomerase activation during cellular proliferation, regulates TERT expression by binding to TERT promoter region and inhibiting DNA methylation at the 5'-CpG island, possibly by interfering with DNMT1 enzyme activity (PubMed:19015635, PubMed:20938050). In addition, impairs keratinocyte differentiation and epidermal function by inhibiting the expression of genes clustered at the epidermal differentiation complex (EDC) as well as GRHL1 and GRHL3 through epigenetic mechanisms (PubMed:23254293). {ECO:0000250|UniProtKB:Q8K5C0, ECO:0000269|PubMed:19015635, ECO:0000269|PubMed:20938050, ECO:0000269|PubMed:20978075, ECO:0000269|PubMed:23254293, ECO:0000269|PubMed:25152456, ECO:0000269|PubMed:29309642, ECO:0000305|PubMed:12175488}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for ZFAND3-GRHL2 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for ZFAND3-GRHL2 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ZFAND3-GRHL2 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for ZFAND3-GRHL2 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | ZFAND3 | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | CTD_human |
| Hgene | ZFAND3 | C0087031 | Juvenile-Onset Still Disease | 1 | CTD_human |
| Hgene | ZFAND3 | C3495559 | Juvenile arthritis | 1 | CTD_human |
| Hgene | ZFAND3 | C3714758 | Juvenile psoriatic arthritis | 1 | CTD_human |
| Hgene | ZFAND3 | C4552091 | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 1 | CTD_human |
| Hgene | ZFAND3 | C4704862 | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 1 | CTD_human |
| Tgene | GRHL2 | C3711374 | Nonsyndromic Deafness | 4 | CLINGEN |
| Tgene | GRHL2 | C0339284 | Polymorphous corneal dystrophy | 1 | ORPHANET |
| Tgene | GRHL2 | C1384666 | hearing impairment | 1 | GENOMICS_ENGLAND |
| Tgene | GRHL2 | C1837640 | Deafness, Autosomal Dominant 28 | 1 | CTD_human;GENOMICS_ENGLAND |
| Tgene | GRHL2 | C4014987 | Nail and tooth abnormalities, marginal palmoplantar keratoderma, oral hyperpigmentation syndrome | 1 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
| Tgene | GRHL2 | C4747961 | CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 4 | 1 | GENOMICS_ENGLAND |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies